Resources

Type of publications
Regions
Diseases

5255 results found

2026 ∙ Khan, B. W. Khattak, M. H. Amjad, M. M. Siddiqui, S. A. Qazi, T. I. Rehmat, H. Khan, M. F. Khan, H. W. Mian, A. M. Ullah, M. Khan, U. Z. Rafay, M. A. Al-Badri, S. G. Bacha, Z.

Comparative Effectiveness of High-Dose and Standard-Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta-Analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Omam, L. A. Jarman, E. Malik, F. Kamwa, V. Mba, C. M.

Containment and response strategies for mpox outbreaks: a systematic review

  • All age groups
  • Mpox
  • Efficacy/effectiveness
  • Administration
  • Coverage
  • Logistics
  • Ethical issues
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Van Sassenbroeck, B. Piessens, V. Roegies, M. Vandijck, D.

Cost-effectiveness analyses of quadrivalent influenza vaccinations in the general European population-a systematic review

  • Europe
  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Mohammed, Y. Olowo-okere, A. Bawa, S. Onah, J. O. Saad, A. Oteri, A. Yusufari, Y. A. Wonodi, C. Umar, Z. A. Kolawole, A. F. Hassan, S. Garba, A. R.

Coverage, effectiveness, and sero-positivity of measles-containing vaccines in low- and lower middle-income countries: An umbrella review of systematic reviews and meta-analyses

  • All age groups
  • Low and Middle Income Countries
  • Measles
  • Coverage
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Faghir-Ganji, M. Abdolmohammadi, N. Ansari-Moghaddam, A. Askari, S. Eshrati, B.

COVID-19 vaccination and stroke risk: A systematic review and meta-analysis of ischemic and hemorrhagic events

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Amanat, N. Hosseini, S. H. Habibisaravi, R. Omrani, M. G.

COVID-19 vaccination hesitancy in pediatrics: a systematic review

  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Menin, I. B. F. Dias, A. D. C. da Rosa, M. I. Colonetti, T. Grande, A. J.

COVID-19 vaccine hesitancy among people with epilepsy: an updated systematic review and meta-analysis

  • Adults
  • COVID-19
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Lotfi, M. Kaderali, L.

Data-driven strategies for model-informed decision-making during the COVID-19 pandemic: a systematic review

  • All age groups
  • COVID-19
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Malik, Z. I. Ahmad, A. M. R. Iqbal, S.

Determinants of HPV vaccine hesitancy in South Asia: a systematic review

  • South-East Asia
  • Eastern Mediterranean
  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Aminu, K. Okeke, E. B. Jayasinghe, Y. A. Maduabuchi, C. N. Olorunlana, A. Akinyemiju, T. Olomo, C. A. Eze, U. Banerjee, A. Ganesh, K. D. M. Salami, A. A. Adegbile, O. E. Narayanan, V. M. Kanmodi, K. K. Nnannah, P. C. Nwebo, R. A.

Determinants of human papillomavirus vaccination uptake in Nigeria: a mixed-methods systematic review

  • Africa
  • Nigeria
  • All age groups
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...